ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001178670-26-000039 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
2,112
Total Value
$0.00
P&L
+inf% (+$617,928.96)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 20, 2026 | Grant/Award | 671 | $0.00 | $0.00 | 1,582 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | May 20, 2026 | Grant/Award | 1,441 | $0.00 | $0.00 | 1,441 | Direct | โ | View Details |